Company news
Regentis Biomaterials Ltd. (AMEX:RGNT) news
Regentis Biomaterials Ltd. news releases on 6ix. Latest, Sep 11, 2026: Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate…
Press releases & updates
Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
September 11, 2026
Regentis Receives Japanese Patent allowance, Strengthening its Global GelrinC Intellectual Property Portfolio with New Proprietary Manufacturing Technology
July 20, 2026
Regentis Biomaterials (RGNT) Receives European Approval for Next-Generation GelrinC Manufacturing Process
July 16, 2026
Regentis Receives European Regulatory Approval for New GelrinC Manufacturing Process, Increasing Production Yield by 400% Ahead of European Commercial Launch
July 15, 2026
Regentis Biomaterials Announces Pricing of a $6.5 Million Private Placement
June 17, 2026
Regentis to Commence European Surgeon Training for GelrinC in Knee Cartilage Repair as Commercial Launch Preparations Accelerate
June 8, 2026
Regentis Biomaterials (RGNT) Advances Simplified Cartilage Repair Platform Toward Key Commercial Milestones
June 1, 2026
Regentis Biomaterials (RGNT) Targets Major Gap in Knee Cartilage Repair Market with Off-the-Shelf Regenerative Implant
May 29, 2026
Regentis Biomaterials : Amendment to Annual Report by Foreign Issuer (Form 20-F/A)
February 27, 2026
Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering
December 5, 2025
Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering
December 3, 2025